Lai Yong, Zhang Qifan, Xu Maohan, Guo Xiurong, Zhou Quan, Liu Qiuyu, Deng Huiling, Song Can
School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Institute of Traditional Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan, China.
Front Nutr. 2025 Jul 10;12:1607365. doi: 10.3389/fnut.2025.1607365. eCollection 2025.
A healthy gut depends on a balance of commensal and probiotic bacteria, and prolonged and inappropriate clinical use of antibiotics can cause an imbalance in the gut flora, resulting in antibiotic-associated diarrhea (AAD). Macrofungal polysaccharides are rich in bioactivities and have attracted much attention for their good performance in anti-inflammatory, antioxidant, anti-obesity and anti-tumor properties. Therefore, we explored the role of water-insoluble polysaccharides (DIPY) in modulating the gut flora to improve AAD.
We initially prepared the water-insoluble polysaccharides derived from . Subsequently, by comprehensively evaluating multiple parameters including the body weight, dietary patterns, cecal histomorphological characteristics, intestinal microbiota composition, concentrations of short-chain fatty acids (SCFAs), and the levels of inflammatory factors in the antibiotic-associated diarrhea (AAD) model animals, we delved into both the action mechanisms of these polysaccharides and their impacts on the intestinal flora and metabolites within C57BL/6J mice.
Our results showed that DIPY effectively ameliorated AAD in mice by modulating the intestinal flora, increasing microbial diversity, the Shannon and Ace index was significantly higher in the DIPY group than in the NR group after the DIPY intervention ( < 0.001). Also, compared with the NR group, DIPY increasing the relative abundance of and , increasing the production of acetic acid ( < 0.001), and decreasing the levels of LPS, MCP-1, TNF-, and IL-6 ( < 0.05) which attenuating inflammatory responses.
This study demonstrated that DIPY has intestinal prebiotic function, which provides a basis for further development of functional products for the treatment of AAD.
健康的肠道依赖于共生菌和益生菌的平衡,而抗生素的长期不当临床使用会导致肠道菌群失衡,引发抗生素相关性腹泻(AAD)。大型真菌多糖具有丰富的生物活性,因其在抗炎、抗氧化、抗肥胖和抗肿瘤特性方面的良好表现而备受关注。因此,我们探讨了水不溶性多糖(DIPY)在调节肠道菌群以改善AAD方面的作用。
我们首先制备了源自……的水不溶性多糖。随后,通过综合评估包括体重、饮食模式、盲肠组织形态学特征、肠道微生物群组成、短链脂肪酸(SCFAs)浓度以及抗生素相关性腹泻(AAD)模型动物体内炎症因子水平等多个参数,我们深入研究了这些多糖的作用机制及其对C57BL/6J小鼠肠道菌群和代谢产物的影响。
我们的结果表明,DIPY通过调节肠道菌群有效改善了小鼠的AAD,增加了微生物多样性,DIPY干预后,DIPY组的香农指数和Ace指数显著高于正常组(<0.001)。此外,与正常组相比,DIPY增加了……和……的相对丰度,增加了乙酸的产生(<0.001),并降低了LPS、MCP - 1、TNF -……和IL - 6的水平(<0.05),从而减轻了炎症反应。
本研究表明DIPY具有肠道益生元功能,为进一步开发治疗AAD的功能性产品提供了依据。